This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Jennifer Baxter - Innovator in Antidiabetic Compounds
Introduction
Jennifer Baxter is a notable inventor based in Morris Plains, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic compounds. Her work focuses on innovative solutions for managing type 2 diabetes and related metabolic conditions.
Latest Patents
Jennifer Baxter holds 1 patent for her invention titled "Crystalline polymorphic forms of an antidiabetic compound." This invention relates to polymorphic forms of a compound that serves as a glucagon receptor antagonist. It is a pharmaceutically active ingredient useful for treating type 2 diabetes, hyperglycemia, obesity, dyslipidemia, and metabolic syndrome. The patent includes various forms such as hydrates, hemihydrates, anhydrates, and similar polymorphic variations.
Career Highlights
Jennifer Baxter is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. Her role involves research and development in the pharmaceutical sector, where she applies her expertise to create effective treatments for diabetes and other related health issues.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues, including John Y L Chung and Aaron S Cote. These partnerships have enhanced her research efforts and contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Jennifer Baxter's work exemplifies the impact of innovation in healthcare, particularly in the treatment of diabetes. Her contributions continue to pave the way for new therapeutic options that improve patient outcomes.